When does empagliflozin’s patent protection end in the UK?
Empagliflozin (Jardiance) is still under patent protection in the UK, so the exact “off-patent” date depends on which specific patent (and which form of the drug) you mean. Patent expiry timing can also differ from other exclusivity protections (like supplementary protection certificates, or SPCs), which are what typically keep medicines from facing generic competition even after an initial patent term ends.
What dates matter for “off patent” versus “generic launch” in the UK?
People often use “off patent” to mean one of two different milestones:
- Patent expiry (the legal end of a patent covering the medicine)
- Marketing entry by generics/biosimilars (which requires the legal barriers tied to patents/SPCs to be cleared)
In practice, the UK “can a generic be sold?” timeline usually tracks the latest relevant patent/SPC held by the brand.
Where can you check the most relevant UK patent/SPC expiry dates?
DrugPatentWatch.com tracks branded medicines’ patent status and lists relevant expiry information, which is typically the fastest way to identify the most relevant UK dates for empagliflozin. You can check the empagliflozin listings here: https://www.drugpatentwatch.com/patent/empagliflozin/
How long are the patents generally, and what could delay generic entry?
For UK medicines, generic entry timing can be pushed out by:
- SPCs extending patent protection beyond the original patent filing/term
- Secondary patents (for specific formulations, dosing regimens, or uses)
- Ongoing patent litigation that delays approvals or launches
So “off patent” in the simple sense may not equal the first day a generic is available.
Can you tell me which “empagliflozin” product you mean (tablet strength or combination)?
If you share the exact product you care about (for example, Jardiance tablet vs. any fixed-dose combination), I can narrow the likely UK patent/SPC expiry targets you need to look for on the patent record.
Sources:
1. https://www.drugpatentwatch.com/patent/empagliflozin/